We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 930 results
  1. A case of membranous nephropathy complicated by Cronkhite–Canada syndrome successfully treated with mizoribine

    Cronkhite–Canada syndrome (CCS) is a non-hereditary disorder characterized by non-neoplastic hamartomatous gastrointestinal polyposis, hair loss,...

    Hiroyuki Nakanoh, Kenji Tsuji, ... Jun Wada in CEN Case Reports
    Article 02 July 2024
  2. Acute renal failure after kidney transplantation due to mizoribine-induced ureteral stones

    Introduction

    Mizoribine (MZR) is used to prevent rejection reactions after kidney transplantation and increase the risk of hyperuricemia. There is a...

    Mao Ding, Hongchao Zhao, Hengcheng Zhu in BMC Nephrology
    Article Open access 03 January 2024
  3. Fanconi syndrome in an elderly patient with membranous nephropathy during treatment with the immunosuppressant mizoribine

    We report on an 80-year-old man diagnosed with Fanconi syndrome induced by mizoribine after 4 weeks of administration to treat membranous...

    Sho Nishikawa, Naoki Takahashi, ... Masayuki Iwano in CEN Case Reports
    Article 24 June 2022
  4. Mizoribine combined with steroids and dietary sodium restriction on the treatment of primary membranous nephropathy: a prospective study

    Background

    We aimed to initially explore the efficiency and safety of mizoribine (MZR) combined with steroids and dietary sodium restriction on the...

    **chao Wang, Miaomiao Zhang, ... Wenxiu Chang in Clinical and Experimental Nephrology
    Article 27 December 2022
  5. The efficacy and safety of mizoribine for maintenance therapy in patients with myeloperoxidase anti-neutrophil cytoplasmic antibody (MPO-ANCA)-associated vasculitis: the usefulness of serum mizoribine monitoring

    Background

    The life prognosis of elderly patients with myeloperoxidase–anti-neutrophil cytoplasmic antibodies-associated vasculitis (MPO-AAV) has been...

    Kaori Mase, Chie Saito, ... Kunihiro Yamagata in Clinical and Experimental Nephrology
    Article 30 July 2022
  6. Mizoribine halts kidney fibrosis in childhood IgA nephropathy: association with modulation of M2-type macrophages

    Background

    The immunosuppressant mizoribine (Miz) can reduce progression of childhood IgA nephropathy (IgAN). This study examined whether Miz affects...

    Yohei Ikezumi, Masatoshi Yoshikane, ... David J. Nikolic-Paterson in Pediatric Nephrology
    Article 10 November 2022
  7. Long-term outcome of combination therapy with corticosteroids, mizoribine and RAS inhibitors as initial therapy for severe childhood IgA vasculitis with nephritis

    Background

    Patients with severe IgA vasculitis with nephritis (IgAVN) typically receive aggressive therapy as an initial approach. We have...

    Sadayuki Nagai, Tomoko Horinouchi, ... Kandai Nozu in Pediatric Nephrology
    Article 29 June 2023
  8. Effect of mizoribine pulse therapy in adult membranous nephropathy

    Membraneous nephropathy (MN) is one of the complicated kidney diseases associated with proteinuria. Mizoribine (MZR) is an emerging treatment option...

    **chao Wang, Miaomiao Zhang, ... Wenxiu Chang in International Urology and Nephrology
    Article 06 November 2020
  9. Mizoribine

    Article 16 January 2021
  10. Mizoribine/prednisolone

    Article 09 January 2021
  11. Conversion from mycophenolate mofetil to mizoribine in the early stages of BK polyomavirus infection could improve kidney allograft prognosis: a single-center study from China

    Background

    Some studies have suggested mizoribine (MZR) could inhibit the replication of BK polyomavirus (BKPyV). The purpose of this study was to...

    ** Li, Dongrui Cheng, ... **song Chen in BMC Nephrology
    Article Open access 02 October 2021
  12. Mizoribine/prednisolone

    Article 10 October 2020
  13. Low-dose corticosteroid with mizoribine might be an effective therapy for elderly-onset ISKDC grade VI IgA vasculitis

    Both the diagnosis of elderly-onset IgA vasculitis (IgAV) and its prognosis can be difficult because of its rarity and the likely presence of...

    Hikaru Sugimoto, Shiho Matsuno, ... Takashi Takei in CEN Case Reports
    Article 04 August 2020
  14. Demographics and treatment of patients with primary membranoproliferative glomerulonephritis in Japan using a national registry of clinical personal records

    Background

    Membranoproliferative glomerulonephritis (MPGN) is a rare glomerular injury that causes nephrotic syndrome and end-stage kidney disease....

    Naoki Nakagawa, Tomonori Kimura, ... Ichiei Narita in Clinical and Experimental Nephrology
    Article Open access 29 July 2023
  15. Heparin/mizoribine

    Article 22 February 2020
  16. Mizoribine/sulfasalazine

    Article 01 February 2020
Did you find what you were looking for? Share feedback.